Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-25 07:00 |
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20…
|
English | 103.7 KB | ||
| 2024-03-22 13:11 |
Document d'enregistrement universel 2023
|
French | 42.7 MB | ||
| 2024-03-22 13:11 |
Document d'enregistrement universel 2023
|
French | 42.7 MB | ||
| 2024-03-21 07:00 |
Valneva fera une présentation sur son vaccin contre le chikungunya, IXCHIQ®, et…
|
French | 151.6 KB | ||
| 2024-03-21 07:00 |
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple …
|
English | 147.1 KB | ||
| 2024-03-20 07:00 |
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlo…
|
English | 589.6 KB | ||
| 2024-03-20 07:00 |
Valneva publie ses résultats financiers 2023 et fait un point sur son activité …
|
French | 692.1 KB | ||
| 2024-03-18 07:00 |
Valneva annonce un report de la date de début de remboursement du prêt contract…
|
French | 190.3 KB | ||
| 2024-03-18 07:00 |
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility wi…
|
English | 121.5 KB | ||
| 2024-03-12 11:24 |
Franchissement de seuil
|
French | 206.4 KB | ||
| 2024-03-06 08:30 |
Déclaration d’actions et de droits de vote de la société Valneva - 29 février 2…
|
French | 14.2 KB | ||
| 2024-03-06 08:30 |
VALNEVA Declaration of shares and voting rights - February 29, 2024
|
English | 14.6 KB | ||
| 2024-03-04 07:00 |
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Inve…
|
English | 138.8 KB | ||
| 2024-03-04 07:00 |
Valneva fera une présentation lors des conférences investisseurs TD Cowen et Va…
|
French | 139.7 KB | ||
| 2024-02-29 07:00 |
Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’uti…
|
French | 210.9 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
